HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings
- Shares (Q2 2026)
- 50
- Value
- $3.50K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 50 | $3.50K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 50 | $2.54K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 50 | $1.48K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 50 | $1.29K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 50 | $1.38K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 50 | $1.42K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 50 | $2.08K | <0.1% | −106−67.9% | Reduced | Holders |
| Q3 2024 | 156 | $10.4K | <0.1% | +5+3.3% | Added | Holders |
| Q2 2024 | 151 | $17.9K | <0.1% | +10+7.1% | Added | Holders |
| Q1 2024 | 141 | $15.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 141 | $14.0K | <0.1% | −244−63.4% | Reduced | Holders |
| Q3 2023 | 385 | $39.8K | <0.1% | +2+0.5% | Added | Holders |
| Q2 2023 | 383 | $46.5K | <0.1% | +1+0.3% | Added | Holders |
| Q1 2023 | 382 | $58.6K | <0.1% | +10+2.7% | Added | Holders |
| Q4 2022 | 372 | $66.8K | <0.1% | −290−43.8% | Reduced | Holders |
| Q3 2022 | 662 | $78.0K | <0.1% | +300+82.9% | Added | Holders |
| Q2 2022 | 362 | $52.0K | <0.1% | +55+17.9% | Added | Holders |
| Q1 2022 | 307 | $53.0K | <0.1% | +6+2.0% | Added | Holders |
| Q4 2021 | 301 | $76.0K | <0.1% | +156+107.6% | Added | Holders |
| Q3 2021 | 145 | $56.0K | <0.1% | +2+1.4% | Added | Holders |
| Q2 2021 | 143 | $34.0K | <0.1% | +3+2.1% | Added | Holders |
| Q1 2021 | 140 | $18.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.